2m 2m 2m 2m 2m 2m 2m
Belite Bio Sp ADR (BLTE)
NASDAQ
$145.35-$1.72 (-1.17%)
Price as of Jun 23, 2026 4:10 PM EDT- $5.9BMarket Cap
- 139.14%1-Year Change
- BiotechnologyIndustry
Belite Bio Sp ADR (BLTE)
$145.35-$1.72 (-1.17%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 49,000 0.00% | 49,000 N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 49,000 0.00% | 49,000 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 38.8M N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -45.4M +51.56% | -29.9M +20.51% | -24.8M +180.12% | -8.9M N/A | |
Depreciation and Amortization Expense | 12,000 +200.00% | 4,000 -97.12% | 139,000 +117.19% | 64,000 N/A | |
Total Operating Expenses | 84.2M +110.54% | 40.0M +26.30% | 31.7M +147.00% | 12.8M N/A | |
Operating Profit | -84.2M +110.54% | -40.0M +26.30% | -31.7M +147.00% | -12.8M N/A | |
Interest Income | 6.6M +77.68% | 3.7M +4,950.00% | 74,000 +221.74% | 23,000 N/A | |
Interest Expense | N/A N/A | N/A N/A | -25,000 +56.25% | -16,000 N/A | |
Interest Income and Expense and Net | 6.6M +77.68% | 3.7M +7,526.53% | 49,000 +600.00% | 7,000 N/A | |
Total Nonoperating Income and Expense | 6.6M +71.00% | 3.9M +8,473.33% | 45,000 -73.99% | 173,000 N/A | |
Income before Taxes | -77.6M +114.76% | -36.1M +14.28% | -31.6M +150.02% | -12.6M N/A | |
Income Taxes | 0 -100.00% | 6,000 -33.33% | 9,000 +800.00% | 1,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -77.6M +114.73% | -36.1M +14.26% | -31.6M +150.09% | -12.6M N/A | |
Net Income from Continuing Operations Applicable to Common | -77.6M +114.76% | -36.1M +14.28% | -31.6M +150.02% | -12.6M N/A | |
Basic EPS and Net Income | -2.31 +95.76% | -1.18 -0.84% | -1.19 +88.89% | -0.63 N/A | |
Diluted EPS and Net Income | -2.31 +95.76% | -1.18 -0.84% | -1.19 +88.89% | -0.63 N/A | |
Basic Weighted Average Shares | 33.5M +9.82% | 30.5M +14.83% | 26.6M +33.12% | 20.0M N/A | |
Diluted Weighted Average Shares | 33.5M +9.82% | 30.5M +14.83% | 26.6M +33.12% | 20.0M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 352.9M +1,014.16% | 31.7M -64.07% | 88.2M +109.45% | 42.1M N/A | |
Short-Term Investments | 4.5M 0.00% | 4.5M -88.61% | 39.9M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 357.5M +886.81% | 36.2M -71.72% | 128.1M +204.35% | 42.1M N/A | |
Total Current Assets | 494.3M +236.07% | 147.1M +63.52% | 89.9M +110.11% | 42.8M N/A | |
Accumulated Depreciation | 507,000 +48.68% | 341,000 +86.34% | 183,000 +101.10% | 91,000 N/A | |
Property and Plant and Equipment and Net | 344,000 -22.52% | 444,000 -9.39% | 490,000 -9.43% | 541,000 N/A | |
Total Long-Term Assets | 286.3M +64,378.38% | 444,000 -9.39% | 490,000 -9.43% | 541,000 N/A | |
Total Assets | 780.6M +413.08% | 152.1M +60.74% | 94.6M +113.77% | 44.3M N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 71,000 N/A | |
Total Current Liabilities | 9.9M +63.34% | 6.0M +66.53% | 3.6M +72.67% | 2.1M N/A | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 188,000 -27.97% | 261,000 -54.84% | 578,000 -13.47% | 668,000 N/A | |
Total Liabilities | 10.1M +59.56% | 6.3M +49.87% | 4.2M +51.91% | 2.8M N/A | |
Retained Earnings | -185.3M +72.10% | -107.6M +50.55% | -71.5M +79.34% | -39.9M N/A | |
Total Stockholders Equity | 770.5M +428.38% | 145.8M +61.25% | 90.4M +117.90% | 41.5M N/A | |
Total Shares Outstanding | 39.3M +23.61% | 31.8M +9.18% | 29.1M +17.07% | 24.9M N/A | |
Cash Flow | |||||
Cash from Operating Activities | -37.0M +26.52% | -29.2M -2.02% | -29.8M +160.40% | -11.5M N/A | |
Capital Expenditures | 71,000 -38.79% | 116,000 +84.13% | 63,000 -84.01% | 394,000 N/A | |
Cash from Investing Activities | -305.1M +175.94% | -110.6M +175,411.11% | -63,000 -84.01% | -394,000 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 663.2M +693.39% | 83.6M +10.05% | 76.0M +105.50% | 37.0M N/A | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -171,853.06% +110.54% | -81,624.49% N/A | N/A N/A | N/A N/A | |
Return on Assets | -16.64% -43.19% | -29.29% -35.68% | -45.54% N/A | N/A N/A | |
Return on Equity | -16.94% -44.64% | -30.60% -36.19% | -47.95% N/A | N/A N/A | |
Revenue Growth | 0.00% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 50.02 +105.75% | 24.31 -1.80% | 24.76 N/A | N/A N/A | |
Cash Ratio | 35.71 +582.11% | 5.24 -78.42% | 24.27 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow